Table 2.
Demographic and clinical characteristics of patients
| Baseline characteristic | No. of patients | (%) or (range) |
|---|---|---|
| Age (years) | ||
| Median | 65 (58–72) | (43–88) |
| < 60 | 30 | 29.7 |
| > 60 | 71 | 70.3 |
| Gender | ||
| Male | 77 | 75.5 |
| Female | 25 | 24.5 |
| Chronic liver disease etiology | ||
| HBV | 12 | 11.7 |
| HCV | 46 | 45.1 |
| Alcoholic | 27 | 26.5 |
| Mixed | 2 | 2.0 |
| Other | 15 | 14.7 |
| CPT class | ||
| A | 86 | 84.3 |
| B | 16 | 15.7 |
| BCLC stage | ||
| A | 48 | 47.1 |
| B | 54 | 53.9 |
| Serum AFP | ||
| < 200 ng/mL | 69 | 67.7 |
| ≥ 200 ng/mL | 33 | 32.4 |
| ALBI | ||
| 1 | 57 | 55.9 |
| 2 | 40 | 39.2 |
| 3 | 5 | 4.9 |
| Number of treated observations | ||
| 1 | 61 | 59.8 |
| 2 | 23 | 22.6 |
| ≥ 3 | 18 | 17.7 |
HBV Hepatitis B virus, HCV Hepatitis C virus, CPT Child–Pugh–Turcotte, BCLC Barcelona clinic liver cancer, AFP α-fetoprotein, ALBI albumin–bilirubin grade